BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33726845)

  • 1. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
    Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
    Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
    Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
    J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells.
    Yue Y; Xia L; Xu S; Wang C; Wang X; Lu W; Xie X
    J Gynecol Oncol; 2020 Jul; 31(4):e46. PubMed ID: 32026660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
    Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.
    Dong Z; Yang L; Lai D
    Cell Prolif; 2013 Aug; 46(4):425-35. PubMed ID: 23869764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma.
    Yang H; Li XD; Zhou Y; Ban X; Zeng TT; Li L; Zhang BZ; Yun J; Xie D; Guan XY; Li Y
    Oncotarget; 2015 Sep; 6(28):26079-89. PubMed ID: 26317793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.
    Ma B; Zhang L; Zou Y; He R; Wu Q; Han C; Zhang B
    J Exp Clin Cancer Res; 2019 Jan; 38(1):23. PubMed ID: 30658712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
    Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
    Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
    Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer stem cells: still an elusive entity?
    Lupia M; Cavallaro U
    Mol Cancer; 2017 Mar; 16(1):64. PubMed ID: 28320418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness.
    Lee H; Kim JW; Lee DS; Min SH
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
    Li X; He J; Ren X; Zhao H; Zhao H
    Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
    Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
    PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Preliminary Study of miR-144 Inhibiting the Stemness of Colon Cancer Stem Cells by Targeting Krüppel-Like Factor 4.
    Qiu Z; Tu L; Hu X; Zhou Z; Lin Y; Ye L; Cui C
    J Biomed Nanotechnol; 2020 Jul; 16(7):1102-1109. PubMed ID: 33308377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
    Wang K; Liu S; Dou Z; Zhang S; Yang X
    Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.